Ly Tran
Family · Richmond, TXNPI 1790541068
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 109 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 18.2% — the pattern of someone who eats at a lot of different presentations.
Across 109 payments — averaging $20.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$401
- Amgen$389
- Pfizer$196
- Mallinckrodt Hospital Products Inc.$172
- UCB, Inc.$135
- AstraZeneca$100
- plus $806 from 18 others
What the payments were for
- Food & beverage$2,199100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 20 | $401 |
| Amgen | 22 | $389 |
| Pfizer | 15 | $196 |
| Mallinckrodt Hospital Products Inc. | 9 | $172 |
| UCB, Inc. | 5 | $135 |
| AstraZeneca | 3 | $100 |
| Novartis | 4 | $93 |
| ANI Pharmaceuticals, Inc. | 3 | $85 |
| Johnson & Johnson | 3 | $81 |
| Aurinia Pharma U.S., Inc. | 3 | $60 |
| CSL Behring | 3 | $55 |
| Sobi, Inc | 2 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $48 |
| Radius Health, Inc. | 2 | $48 |
| Biocryst US Sales Co., LLC | 2 | $41 |
| E.r. Squibb & Sons, L.L.C. | 2 | $41 |
| Grifols USA, LLC | 2 | $35 |
| Sandoz | 1 | $33 |
| Lilly USA, LLC | 1 | $27 |
| Biocon Biologics Inc | 1 | $26 |
| Tersera Therapeutics LLC | 1 | $22 |
| Fresenius Kabi USA, LLC | 1 | $22 |
| Pharming Healthcare, Inc. | 1 | $17 |
| GSK | 1 | $16 |
How this compares
$2,199 in reported general payments places this provider in the 80th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxychloroquine Sulfate | 12 | $419 |
| MethotrexateMethotrexate Sodium | 11 | $236 |
| Celecoxib | 11 | $142 |
Paid to pharmacies, not to this prescriber.
Other family in Richmond
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
- Stephanie RodriguezCorpus Christi$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.